{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-377696","form_type":"8-K","ticker":"BMRN","cik":"0001048477","company_name":"BIOMARIN PHARMACEUTICAL INC","filed_at":"2026-09-01T13:23:17+00:00","discovered_at":"2026-09-01T13:24:02.383714+00:00","generated_at":"2026-09-01T13:24:12.255302+00:00","sec_items":["8.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"BioMarin completes acquisition of Alesta Therapeutics B.V.","bullets":["Completed share purchase of Alesta Therapeutics on Aug 31, 2026; Alesta now wholly owned subsidiary.","Acquisition follows Share Purchase Agreement first filed Aug 18, 2026; no new deal terms disclosed.","BioMarin (BMRN) expands portfolio via Alesta; purchase price not stated in this 8-K."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-377696","json":"https://secwatch.observer/filing/0001193125-26-377696.json","markdown":"https://secwatch.observer/filing/0001193125-26-377696.md","text":"https://secwatch.observer/filing/0001193125-26-377696.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1048477/000119312526377696/0001193125-26-377696-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1048477/000119312526377696/d110660d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-01T13:24:12.255302+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}